Stonepine Capital Management, LLC
Filing Date
Global Rank
#4,924
/ 8,700
▲ 473
Top Industry
Biotechnology
76.3%
Period ended 2 months ago
Filed Aug 17, 2026 · 27d
26 quarters · since Mar 2020
Portfolio Concentration
83 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
8.1%
−34.2 pts
Top 5
32.9%
−33.9 pts
Top 10
49.3%
−27.4 pts
HHI
347
Diversified−1,637
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $171,511,776 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
22 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| KTTA | Pasithea Therapeutics Corp. | +1,370,167 | 2,201,468 | $1,133,756 | |
| CABA | Cabaletta Bio, Inc. | +867,100 | 917,100 | $2,852,181 | |
| EDSA | Edesa Biotech, Inc. | +426,439 | 456,439 | $3,710,849 | |
| MSLE | Satellos Bioscience Inc. | +391,624 | 491,624 | $3,822,376 | |
| XLO | Xilio Therapeutics, Inc. | +161,832 | 225,994 | $2,165,022 | |
| QNRX | Quoin Pharmaceuticals Ltd. | +146,026 | 199,486 | $965,512 | |
| AYTU | Aytu Biopharma, Inc | +120,632 | 912,921 | $1,962,780 | |
| CNTB | Connect Biopharma Holdings Ltd | +54,254 | 364,254 | $866,924 | |
| VSTM | Verastem, Inc. | +47,327 | 3,349,627 | $12,795,575 | |
| LUNG | Pulmonx Corp | +47,148 | 815,436 | $1,060,066 | |
| TELA | TELA Bio, Inc. | +45,175 | 2,662,427 | $1,996,820 | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | +41,538 | 425,000 | $3,986,500 | |
| NKTR | Nektar Therapeutics | +35,654 | 120,654 | $8,422,855 | |
| PHAT | Phathom Pharmaceuticals, Inc. | +35,000 | 85,010 | $922,358 | |
| ARVN | Arvinas, Inc. | +32,500 | 60,000 | $498,600 | |
| IRD | Opus Genetics, Inc. | +32,030 | 100,718 | $413,950 | |
| INAB | In8bio, Inc. | +31,875 | 695,287 | $980,354 | |
| ACET | Adicet Bio, Inc. | +23,563 | 245,518 | $2,121,275 | |
| SABS | SAB Biotherapeutics, Inc. | +23,271 | 73,271 | $285,756 | |
| OKYO | OKYO Pharma Ltd | +12,996 | 862,996 | $1,294,494 | |
| KLRS | Kalaris Therapeutics, Inc. | +9,722 | 30,122 | $122,596 | |
| PLRX | Pliant Therapeutics, Inc. | +5,888 | 230,538 | $262,813 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| HRTX | Heron Therapeutics, Inc. /De/ | −911,404 | 1,490,787 | $641,038 | |
| IKT | Inhibikase Therapeutics, Inc. | −561,023 | 396,179 | $804,243 | |
| ADMA | Adma Biologics, Inc. | −500,000 | 1,390,000 | $11,634,300 | |
| BOLD | Boundless Bio, Inc. | −443,087 | 154,595 | $386,487 | |
| CRIS | Curis Inc | −414,221 | 3,312,185 | $1,722,336 | |
| TENX | Tenax Therapeutics, Inc. | −315,200 | 660,000 | $9,603,000 | |
| CDXS | Codexis, Inc. | −308,332 | 109,662 | $247,836 | |
| ABEO | Abeona Therapeutics Inc. | −289,303 | 557,284 | $3,444,015 | |
| MNKD | Mannkind Corp | −266,300 | 250,000 | $1,065,000 | |
| MXCT | Maxcyte, Inc. | −253,067 | 751,606 | $924,475 | |
| ZVRA | Zevra Therapeutics, Inc. | −221,299 | 258,701 | $3,709,772 | |
| CTMX | CytomX Therapeutics, Inc. | −195,000 | 205,000 | $768,750 | |
| PMVP | PMV Pharmaceuticals, Inc. | −172,016 | 536,086 | $718,355 | |
| EOLS | Evolus, Inc. | −168,929 | 2,010,162 | $13,950,524 | |
| ANTX | AN2 Therapeutics, Inc. | −162,153 | 551,692 | $2,670,189 | |
| XFOR | X4 Pharmaceuticals, Inc | −110,320 | 224,989 | $1,050,698 | |
| ZNTL | Zentalis Pharmaceuticals, Inc. | −107,517 | 161,583 | $783,677 | |
| NMRA | Neumora Therapeutics, Inc. | −100,000 | 500,000 | $850,000 | |
| CGEN | Compugen Ltd | −72,913 | 31,387 | $67,168 | |
| POCI | Precision Optics Corporation, Inc. | −53,610 | 46,390 | $236,589 | |
| BCAB | BioAtla, Inc. | −48,955 | 16,432 | $68,028 | |
| CBIO | Crescent Biopharma, Inc. | −45,000 | 40,000 | $720,000 | |
| XERS | Xeris Biopharma Holdings, Inc. | −40,030 | 280,000 | $2,217,600 | |
| BIOA | BioAge Labs, Inc. | −30,000 | 20,000 | $490,200 | |
| CNSP | CNS Pharmaceuticals, Inc. | −19,427 | 41,573 | $198,718 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
23 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | 225,000 | $7,512,750 | |
| ELOX | Eloxx Pharmaceuticals, Inc. | 397,160 | $5,512,580 | |
| INSM | INSMED Inc | 40,000 | $4,264,800 | |
| INDV | Indivior Pharmaceuticals, Inc. | 100,000 | $4,103,000 | |
| MDT | Medtronic plc | 50,000 | $3,911,500 | |
| ABT | Abbott Laboratories | 40,000 | $3,629,600 | |
| BMRN | Biomarin Pharmaceutical Inc | 50,000 | $2,861,000 | |
| BSX | Boston Scientific Corp | 50,000 | $2,134,000 | |
| SPRB | Spruce Biosciences, Inc. | 28,795 | $1,554,930 | |
| MLTX | MoonLake Immunotherapeutics | 50,000 | $973,500 | |
| AZTR | Azitra, Inc. | 5,285,476 | $887,959 | |
| NVCT | Nuvectis Pharma, Inc. | 40,000 | $735,600 | |
| ORKA | Oruka Therapeutics, Inc. | 7,500 | $713,775 | |
| CALC | CalciMedica, Inc. | 622,432 | $641,104 | |
| NGEN | Nervgen Pharma Corp. | 271,678 | $559,656 | |
| QTI | Qt Imaging Holdings, Inc. | 100,000 | $407,000 | |
| SINT | Sintx Technologies, Inc. | 209,205 | $391,213 | |
| CLRB | Cellectar Biosciences, Inc. | 104,550 | $290,649 | |
| EPRX | Eupraxia Pharmaceuticals Inc. | 43,491 | $287,475 | |
| ANL | Adlai Nortye Group Ltd. | 24,257 | $278,955 | |
| SENS | Senseonics Holdings, Inc. | 48,680 | $276,502 | |
| RNTX | Rein Therapeutics, Inc. | 218,038 | $226,759 | |
| HUMA | Humacyte, Inc. | 231,299 | $180,413 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
12 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| BWX | State Street SPDR Bloomberg International Treasury Bond ETF | 800,000 | $102,184,000 | |
| ESTA | Establishment Labs Holdings Inc. | 56,000 | $3,179,680 | |
| ARE | Alexandria Real Estate Equities, Inc. | 50,000 | $2,321,000 | |
| ACAD | Acadia Pharmaceuticals Inc | 100,000 | $2,226,000 | |
| SRZN | Surrozen, Inc./DE | 33,005 | $961,435 | |
| VRCA | Verrica Pharmaceuticals Inc. | 99,735 | $527,598 | |
| CADL | Candel Therapeutics, Inc. | 102,500 | $502,250 | |
| JANX | Janux Therapeutics, Inc. | 20,000 | $278,000 | |
| OABI | OmniAb, Inc. | 164,045 | $257,550 | |
| ELDN | Eledon Pharmaceuticals, Inc. | 35,000 | $107,800 | |
| — | 69,500 | $0 | ||
| — | 100,000 | $0 | ||
| No positions match the current search. | ||||
83 tracked positions ·
$171,511,776 total
· filing declares
87 positions · $177,260,827
· as of Jun 30, 2026
Showing 1–50
of 83 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| EOLS |
Evolus, Inc.
CALL
+ SHARES
Healthcare
|
Reduced | 2,010,162 | $13,950,524 | 8.13% | |
| VSTM |
Verastem, Inc.
Healthcare
|
Added | 3,349,627 | $12,795,575 | 7.46% | |
| ADMA |
Adma Biologics, Inc.
CALL
+ SHARES
Healthcare
|
Reduced | 1,390,000 | $11,634,300 | 6.78% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
Reduced | 660,000 | $9,603,000 | 5.60% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
Added | 120,654 | $8,422,855 | 4.91% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
CALL
+ SHARES
Healthcare
|
NEW | 225,000 | $7,512,750 | 4.38% | |
| CAMP |
Camp4 Therapeutics Corp
Healthcare
|
Held | 1,389,622 | $6,072,648 | 3.54% | |
| ELOX |
Eloxx Pharmaceuticals, Inc.
Healthcare
|
NEW | 397,160 | $5,512,580 | 3.21% | |
| KZIA |
Kazia Therapeutics Ltd
Healthcare
|
Held | 345,179 | $4,860,120 | 2.83% | |
| INSM |
INSMED Inc
CALL
Healthcare
|
NEW | 40,000 | $4,264,800 | 2.49% | |
| INDV |
Indivior Pharmaceuticals, Inc.
Healthcare
|
NEW | 100,000 | $4,103,000 | 2.39% | |
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
Healthcare
|
Added | 425,000 | $3,986,500 | 2.32% | |
| MDT |
Medtronic plc
CALL
Healthcare
|
NEW | 50,000 | $3,911,500 | 2.28% | |
| MSLE |
Satellos Bioscience Inc.
Healthcare
|
Added | 491,624 | $3,822,376 | 2.23% | |
| EDSA |
Edesa Biotech, Inc.
Healthcare
|
Added | 456,439 | $3,710,849 | 2.16% | |
| ZVRA |
Zevra Therapeutics, Inc.
Healthcare
|
Reduced | 258,701 | $3,709,772 | 2.16% | |
| ABT |
Abbott Laboratories
CALL
Healthcare
|
NEW | 40,000 | $3,629,600 | 2.12% | |
| ABEO |
Abeona Therapeutics Inc.
Healthcare
|
Reduced | 557,284 | $3,444,015 | 2.01% | |
| BMRN |
Biomarin Pharmaceutical Inc
CALL
Healthcare
|
NEW | 50,000 | $2,861,000 | 1.67% | |
| CABA |
Cabaletta Bio, Inc.
Healthcare
|
Added | 917,100 | $2,852,181 | 1.66% | |
| ANTX |
AN2 Therapeutics, Inc.
Healthcare
|
Reduced | 551,692 | $2,670,189 | 1.56% | |
| XERS |
Xeris Biopharma Holdings, Inc.
CALL
Healthcare
|
Reduced | 280,000 | $2,217,600 | 1.29% | |
| XLO |
Xilio Therapeutics, Inc.
Healthcare
|
Added | 225,994 | $2,165,022 | 1.26% | |
| BSX |
Boston Scientific Corp
CALL
Healthcare
|
NEW | 50,000 | $2,134,000 | 1.24% | |
| ACET |
Adicet Bio, Inc.
Healthcare
|
Added | 245,518 | $2,121,275 | 1.24% | |
| TELA |
TELA Bio, Inc.
Healthcare
|
Added | 2,662,427 | $1,996,820 | 1.16% | |
| AYTU |
Aytu Biopharma, Inc
Healthcare
|
Added | 912,921 | $1,962,780 | 1.14% | |
| CRIS |
Curis Inc
Healthcare
|
Reduced | 3,312,185 | $1,722,336 | 1.00% | |
| SIBN |
SI-BONE, Inc.
CALL
Healthcare
|
Reduced | 100,000 | $1,632,000 | 0.95% | |
| SPRB |
Spruce Biosciences, Inc.
Healthcare
|
NEW | 28,795 | $1,554,930 | 0.91% | |
| OKYO |
OKYO Pharma Ltd
Healthcare
|
Added | 862,996 | $1,294,494 | 0.75% | |
| DCTH |
Delcath Systems, Inc.
CALL
Healthcare
|
Held | 100,000 | $1,259,000 | 0.73% | |
| KTTA |
Pasithea Therapeutics Corp.
Healthcare
|
Added | 2,201,468 | $1,133,756 | 0.66% | |
| SLGL |
Sol-Gel Technologies Ltd.
Healthcare
|
Reduced | 14,469 | $1,072,731 | 0.63% | |
| MNKD |
Mannkind Corp
CALL
Healthcare
|
Reduced | 250,000 | $1,065,000 | 0.62% | |
| LUNG |
Pulmonx Corp
Healthcare
|
Added | 815,436 | $1,060,066 | 0.62% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
Reduced | 224,989 | $1,050,698 | 0.61% | |
| INAB |
In8bio, Inc.
Healthcare
|
Added | 695,287 | $980,354 | 0.57% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
NEW | 50,000 | $973,500 | 0.57% | |
| QNRX |
Quoin Pharmaceuticals Ltd.
Healthcare
|
Added | 199,486 | $965,512 | 0.56% | |
| MXCT |
Maxcyte, Inc.
Healthcare
|
Reduced | 751,606 | $924,475 | 0.54% | |
| PHAT |
Phathom Pharmaceuticals, Inc.
Healthcare
|
Added | 85,010 | $922,358 | 0.54% | |
| AZTR |
Azitra, Inc.
Healthcare
|
NEW | 5,285,476 | $887,959 | 0.52% | |
| CNTB |
Connect Biopharma Holdings Ltd
Healthcare
|
Added | 364,254 | $866,924 | 0.51% | |
| HELP |
Cybin Inc.
Healthcare
|
Reduced | 129,280 | $854,540 | 0.50% | |
| NMRA |
Neumora Therapeutics, Inc.
CALL
Healthcare
|
Reduced | 500,000 | $850,000 | 0.50% | |
| IKT |
Inhibikase Therapeutics, Inc.
Healthcare
|
Reduced | 396,179 | $804,243 | 0.47% | |
| ZNTL |
Zentalis Pharmaceuticals, Inc.
Healthcare
|
Reduced | 161,583 | $783,677 | 0.46% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
Reduced | 205,000 | $768,750 | 0.45% | |
| ARDX |
Ardelyx, Inc.
CALL
Healthcare
|
Held | 150,000 | $765,000 | 0.45% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.